v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Stock
Common Stock Warrants
Common Stock
Existing warrants
Common Stock
Additional Paid in Capital
Common Stock Warrants
Additional Paid in Capital
Existing warrants
Additional Paid in Capital
Accumulated Deficit
Common Stock Warrants
Existing warrants
Total
Beginning balance at Dec. 31, 2024 [1]     $ 1,750     $ 9,323,403 $ (28,665,216)     $ (19,340,063)
Beginning balance (in shares) at Dec. 31, 2024 [1]     17,500,000              
Net income (loss)             (327,526)     (327,526)
Ending balance at Mar. 31, 2025 [1]     $ 1,750     9,323,403 (28,992,742)     (19,667,589)
Ending balance (in shares) at Mar. 31, 2025 [1]     17,500,000              
Beginning balance at Dec. 31, 2024 [1]     $ 1,750     9,323,403 (28,665,216)     (19,340,063)
Beginning balance (in shares) at Dec. 31, 2024 [1]     17,500,000              
Net income (loss)                   (214,239)
Ending balance at Jun. 30, 2025     $ 2,601     20,069,442 (28,879,455)     (8,807,412)
Ending balance (in shares) at Jun. 30, 2025     26,014,633              
Beginning balance at Mar. 31, 2025 [1]     $ 1,750     9,323,403 (28,992,742)     (19,667,589)
Beginning balance (in shares) at Mar. 31, 2025 [1]     17,500,000              
Business combination with IRIS, net of transaction costs     $ 11     190,379       190,390
Business combination with IRIS, net of transaction costs (in shares)     114,633              
Settlement of loans to Iris Acquisition Corp upon closing of the business combination           (4,443,500)       (4,443,500)
Issuance of common stock to Iris Acquisition Holdings, LLC     $ 690     (690)        
Issuance of common stock to Iris Acquisition Holdings, LLC (in shares)     6,900,000              
Issuance of common stock     $ 150     14,999,850       15,000,000
Issuance of common stock (in shares)     1,500,000              
Net income (loss)             113,287     113,287
Ending balance at Jun. 30, 2025     $ 2,601     20,069,442 (28,879,455)     (8,807,412)
Ending balance (in shares) at Jun. 30, 2025     26,014,633              
Beginning balance at Dec. 31, 2025     $ 2,706     29,054,337 (38,871,733)     $ (9,814,690)
Beginning balance (in shares) at Dec. 31, 2025     27,064,633             27,064,633
Issuance of common stock in connection with the Clear Street settlement (in shares)     4,000,000              
Issuance of common stock in connection with the Clear Street settlement     $ 400     7,359,600       $ 7,360,000
Issuance of common stock     $ 1,381     3,444,427       3,445,808
Issuance of common stock (in shares)     13,813,000              
Net income (loss)             (1,123,714)     (1,123,714)
Ending balance at Mar. 31, 2026     $ 4,487     39,858,364 (39,995,447)     (132,596)
Ending balance (in shares) at Mar. 31, 2026     44,877,633              
Beginning balance at Dec. 31, 2025     $ 2,706     29,054,337 (38,871,733)     $ (9,814,690)
Beginning balance (in shares) at Dec. 31, 2025     27,064,633             27,064,633
Net income (loss)                   $ (2,530,973)
Ending balance at Jun. 30, 2026     $ 5,597     41,697,721 (41,402,706)     $ 300,612
Ending balance (in shares) at Jun. 30, 2026     55,971,633             55,971,633
Beginning balance at Mar. 31, 2026     $ 4,487     39,858,364 (39,995,447)     $ (132,596)
Beginning balance (in shares) at Mar. 31, 2026     44,877,633              
Issuance of common stock in connection with warrants $ 75 $ 1,035   $ 217,425 $ 1,621,932     $ 217,500 $ 1,622,967  
Issuance of common stock in connection with warrants (in shares) 750,000 10,344,000                
Net income (loss)             (1,407,259)     (1,407,259)
Ending balance at Jun. 30, 2026     $ 5,597     $ 41,697,721 $ (41,402,706)     $ 300,612
Ending balance (in shares) at Jun. 30, 2026     55,971,633             55,971,633
[1] Shares, common stock amount and additional paid - in capital data are presented on a retroactive basis to reflect the effects of the conversion and recapitalization as a result of the Business Combination consummated on April 30, 2025.